What is the appropriate outpatient management for an 86-year-old patient with elevated liver function tests?

Management of Elevated Liver Enzymes in an 86-Year-Old Patient

For an 86-year-old with elevated liver enzymes, immediately perform a comprehensive liver aetiology screen including abdominal ultrasound, viral hepatitis testing, autoimmune markers, and iron studies, then risk-stratify for fibrosis using age-adjusted FIB-4 or NAFLD Fibrosis Score cutoffs (FIB-4 <2.0 or NFS <0.12 for patients >65 years), with referral to hepatology if scores indicate high risk or if the etiology remains unclear after initial workup. 1

Initial Assessment and Workup

Step 1: Review Context and Pattern

• Do not simply repeat the same liver tests - 84% of abnormal results remain abnormal at 1 month, and 75% at 2 years 1
• Review previous results, past medical history, and current medications (prescribed, over-the-counter, herbal) 1
• The degree of enzyme elevation does not necessarily correlate with clinical significance - context matters 1

Step 2: Complete the Liver Blood Test Panel

Ensure you have the complete panel if not already done:

• Bilirubin, albumin, ALT, alkaline phosphatase (ALP), GGT
• Full blood count (if not done in past 12 months)
• INR and platelet count to assess synthetic function 1

Step 3: Perform Standard Liver Aetiology Screen

Order these tests simultaneously 1:

• Abdominal ultrasound (to assess liver architecture, exclude biliary obstruction, identify steatosis)
• Hepatitis B surface antigen
• Hepatitis C antibody (with reflex PCR if positive)
• Autoimmune markers: anti-mitochondrial antibody, anti-smooth muscle antibody, antinuclear antibody
• Serum immunoglobulins
• Iron studies: simultaneous serum ferritin and transferrin saturation

Step 4: Targeted History Elements

Focus on specific risk factors:

• Alcohol intake: Use AUDIT-C screening, then full AUDIT if positive (score >19 warrants alcohol services referral) 1
• Metabolic syndrome features: BMI >25, type 2 diabetes, hypertension, dyslipidemia (NAFLD risk factors) 1
• Medications: Recent additions, statins, antibiotics, supplements
• Country of birth/ethnicity: Strongest predictor of viral hepatitis risk 1

Age-Specific Fibrosis Risk Stratification

Critical for patients >65 years: Use modified cutoff values 1

First-Line Fibrosis Assessment

Calculate FIB-4 or NAFLD Fibrosis Score using age-adjusted thresholds 1:

• FIB-4 <2.0 (not <1.3) indicates low risk in patients >65 years
• **NFS <0.12** (not ≤-1.455) indicates low risk in patients >65 years
• These higher cutoffs account for age-related changes in liver function 1

Second-Line Testing (if indeterminate or high first-line scores)

• Enhanced Liver Fibrosis (ELF) test or
• FibroScan/ARFI elastography 1
• FibroScan >7.8 kPa suggests advanced fibrosis requiring hepatology referral 1

Decision Points for Referral

Urgent Referral to Secondary Care (same day/within days)

• Marked derangement of liver tests with synthetic failure (low albumin, elevated INR)
• Clinical signs of decompensation (jaundice, ascites, encephalopathy)
• Dilated bile ducts on ultrasound suggesting obstruction 1
• ALT >1000 U/L (consider acute viral hepatitis, drug-induced injury, ischemic hepatitis) 1

Routine Hepatology Referral (within weeks)

• Positive hepatitis B or C serology 1
• Positive autoimmune markers (especially with elevated IgG) 1
• Elevated ferritin AND transferrin saturation >45% (hemochromatosis) 1
• FibroScan >16 kPa or high-risk fibrosis scores 1
• Abnormal liver tests with negative aetiology screen and no NAFLD risk factors - treatable conditions like autoimmune hepatitis may have negative initial antibodies 1

Outpatient Management with Monitoring

If workup suggests NAFLD with low fibrosis risk:

• Lifestyle modification (weight loss if BMI >25, dietary changes)
• Manage metabolic syndrome components (diabetes control, lipid management)
• Repeat fibrosis assessment in 2-3 years 1

Common Pitfalls in Elderly Patients

1. Assuming normal tests exclude disease: Normal ALT/AST do not rule out cirrhosis, especially in NAFLD 1
2. Using wrong age cutoffs: Standard FIB-4 and NFS thresholds underperform in patients >65 years 1
3. Isolated elevated ferritin: Often reflects dysmetabolic iron overload (NAFLD, alcohol) rather than hemochromatosis - check transferrin saturation 1
4. Dismissing mild elevations: Even mild ALT elevations associate with increased liver-related mortality 2
5. Missing autoimmune hepatitis: May present with negative autoantibodies initially - refer if unexplained persistent elevation 1

Special Considerations at Age 86

• Polypharmacy risk: Drug-induced liver injury more common; review all medications including supplements 1
• Frailty assessment: Consider goals of care when planning invasive testing
• Comorbidity burden: Weigh risks/benefits of liver biopsy if diagnosis remains unclear after non-invasive testing
• Alcohol screening: Don't assume low consumption based on age - use validated tools 1